Evidence map›Paper›PMID 41838271›Full record

ReviewOphthalmology and therapy2026

From Science and Technology to Eye-Health Policy: A Review on Global and Asia-Pacific Strategies on the Prevention of Blindness from Retinal Diseases.

Taraprasad Das, Subhadra Jalali, Jost Jonas, Ryo Kawasaki, Seang Mei Saw, Sobha Sivaprasad, Anna C S Tan, Paisan Ruamviboonsuk

Abstract readReview
In one paragraph

Review in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Taraprasad Das *Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, 500034, India. tpdbei@gmail.com.
Subhadra JalaliAnant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, 500034, India.
Jost JonasAnant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, 500034, India.
Ryo KawasakiDivision of Public Health, Department of Social Medicine, Graduate School of Medicine, University of Osaka, Osaka, Japan.
Seang Mei SawSingapore Eye Research Institute, Singapore National Eye Center, Singapore, Singapore.
Sobha SivaprasadNIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
Anna C S TanSingapore Eye Research Institute, Singapore National Eye Center, Singapore, Singapore.
Paisan Ruamviboonsuk *College of Medicine, Rangsit University, Bangkok, Thailand. paisan.trs@gmail.com.ORCID http://orcid.org/0000-0001-6114-6220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization (WHO) is making a concerted effort to enhance health, including eye health and overall well-being. This global effort has resulted in a reduced age-standardized prevalence of avoidable blindness and no increase in avoidable moderate and severe vision impairment. However, the absolute number of cases has increased for both avoidable blindness and moderate-to-severe vision impairment. Globally, the leading causes of visual impairment include uncorrected refractive errors and cataract, though many retinal conditions equally contribute. All causes of blindness and moderate-to-severe visual impairment are higher in low- and middle-income countries, including many in the Asia-Pacific region. This inequality could be reduced by harmonizing science and technology and translating them into regulatory policy to close the care loop.This review aimed to provide a perspective on the disease burden of common retinal conditions such as diabetic retinopathy, age-related macular degeneration, myopia, and retinopathy of prematurity; the latest science and technology for diagnosing and treating these conditions; and recommendations to translate them into national policy. We also reviewed the WHO's global policy and targets related to the United Nations Sustainable Development Goals, recommended to prevent global blindness by the year 2030. The national health and eye care systems, from primary to tertiary care, in an Asia-Pacific country, which align with "Integrated People-Centered Eye Care" proposed by WHO, are also reviewed.

Indexed as

EyecareHealth policyRetinal disordersScienceTechnology

Identifiers

PMID41838271
PMCPMC13047002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.